MRNY250117P17000
- 12.83
- -0.29-2.21%
YIELDMAX MRNA OPTION INCOME STRATEGY ETF Newsroom
Express News | Moderna : Berenberg Cuts Target Price to $33 From $42
Moderna Options Spot-On: On January 15th, 119.79K Contracts Were Traded, With 812.67K Open Interest
Wall Street Today: JPM and Banking Leads Market Higher
McKesson, Vertex Pharmaceuticals Among Top Healthcare Quant Picks Before Q4 Earnings
Is Moderna (MRNA) the Stock That Will Go to the Moon According to Reddit?
Moderna Price Target Drops, Fintech Outperform, FDA Hits Tobacco
Moderna Struggles With COVID-19 Vaccine Market Share, Pipeline Progress, Morgan Stanley Says
Live Stock: Banks Break the Bank on Earnings, Inflation Looks Tame for Dec
Moderna Target Nearly Halved by Morgan Stanley on Weak Guidance
Moderna Is Maintained at Equal-Weight by Morgan Stanley
Moderna Remains the Most Shorted Stock Among S&P 500 Healthcare Stocks in the Last Month of 2024
Moderna Analyst Ratings
Morgan Stanley Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $38
Express News | Moderna Inc : Morgan Stanley Cuts Target Price to $38.00 From $70.00
Is Moderna Stock a No-Brainer Buy on the Sell-Off?
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
Moderna Options Spot-On: On January 14th, 93,043 Contracts Were Traded, With 789.01K Open Interest
Wall Street Today: Market Barely Climbs, Wholesale Inflation Grows Less Than Feared
JP Morgan 2025: Moderna Stock Suffers After CEO Reveals Conservative 2025 Guidance
Unusual Options Activity: MDB, PCG and Others Attract Market Bets, MDB V/OI Ratio Reaches 95.2